Tag: Crizotinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Crizotinib

Targeted Drug ROS1 Inhibitors For NSCLC Market Size, Trends, and Key Players

Added to Collection on: 2021-09-04 13:59:51

Tags for this article:

Chemical compounds
Organic compounds
Lung cancer
Orphan drugs
Tyrosine kinase receptors
ROS1
Chloroarenes
Non-small-cell lung carcinoma
Entrectinib
Crizotinib
Lorlatinib
ALK inhibitor

Click the tags to see associated articles and topics

View Article Details
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study ...

Added to Collection on: 2021-10-23 13:44:14

Tags for this article:

Tyrosine kinase receptors
Organ systems
Cancer
Branches of biology
ROS1
ALK inhibitor
Anaplastic lymphoma kinase
Inflammatory myofibroblastic tumour
Neuroblastoma
Radiation therapy
Entrectinib
Crizotinib
Turning Point Therapeutics, Inc.

Click the tags to see associated articles and topics

View Article Details
ALK rearrangement in small-cell lung cancer | OTT - Dove Medical Press

Added to Collection on: 2021-10-23 14:42:51

Tags for this article:

Chemical compounds
Lung cancer
Cancer
Organic compounds
Piperidines
Tyrosine kinase receptors
Breakthrough therapy
Anaplastic lymphoma kinase
Non-small-cell lung carcinoma
Alectinib
Crizotinib
Protein kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung ...

Added to Collection on: 2022-01-28 18:08:35

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
ALK inhibitor
Alectinib

Click the tags to see associated articles and topics

View Article Details
Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer - Entrepreneur

Added to Collection on: 2022-01-31 18:16:09

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Alectinib

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena shows PFS improvement in Phase III lung cancer trial

Added to Collection on: 2022-04-11 14:12:56

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Lung cancer
Tyrosine kinase receptors
Piperidines
ALK inhibitor
Orphan drugs
Anaplastic lymphoma kinase
Crizotinib
Lorlatinib
Non-small-cell lung carcinoma
XALKORI
pfizer global

Click the tags to see associated articles and topics

View Article Details
BMS bets $4.1B on lung cancer drug that could best products from Pfizer, Roche

Added to Collection on: 2022-06-03 19:24:01

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Tyrosine kinase receptors
Breakthrough therapy
ROS1
Lung cancer
Orphan drugs
Entrectinib
Anaplastic lymphoma kinase
Non-small-cell lung carcinoma
Crizotinib

Click the tags to see associated articles and topics

View Article Details
Non Small Cell Lung Cancer Therapeutics Market Size Share Trends Growth Statistics and ...

Added to Collection on: 2022-09-05 08:51:41

Tags for this article:

Health
Lung cancer
Companies
Cancer
Non-small-cell lung carcinoma
Small-cell carcinoma
Pharmaceutical industry in China
Targeted therapy
Boehringer Ingelheim
Genentech
Crizotinib
Merck & Co.

Click the tags to see associated articles and topics

View Article Details
Updates: MET targeted therapy for EXON 14 mutations in lung cancer - EurekAlert!

Added to Collection on: 2023-09-12 13:58:34

Tags for this article:

Breakthrough therapy
Lung cancer
Orphan drugs
Antineoplastic drugs
Chloroarenes
Crizotinib
Non-small-cell lung cancer
Capmatinib
Tyrosine kinase
Protein kinase inhibitor
Tepotinib
ROS1

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details